Three cases of ovarian cancer treated with High Dose Chemotherapy (HDC) combined with Peripheral Blood Stem Cell Transplantation (PBSCT) —Retrospective Analysis of harvest ratio of peripheral stem cells—

Bibliographic Information

Other Title
  • 末梢血幹細胞移植術を併用し超大量化学療法を施行した卵巣癌の3症例一末梢血幹細胞採取についての検討一

Description

Recently, several applications of HDC (High Dose Chemotherapy) combined with PBSCT (Peripheral Blood Stem Cell Transplantation) to ovarian cancer treatment revealed in many hospitals. We had experienced three ovarian cancer cases treated with HDC combined with PBSCT. We estimated these cases about the appropriate agents combination for mobilization chemotherapy, the use of G-CSF (Granulocyte Colony Stimulating Factor) and the suitable time of peripheral blood stem cell harvest under monitoring of CD34 as a stem cell marker. High CD34 positive stem cell harvest ratio was obtained, when bone marrow suppression preceding induction chemotherapy was strong, G-CSF application was started at the point nadir of peripheral white blood cells and PBSCI-I was carried out at the time of stem cells mobilization into peripheral blood. [Adv Obstet Gynecol 49 (5): 554-562, 1997 (H9.9)]

Journal

Details 詳細情報について

  • CRID
    1390282679923501440
  • NII Article ID
    130004069598
  • DOI
    10.11437/sanpunosinpo1949.49.554
  • ISSN
    13476742
    03708446
  • Text Lang
    ja
  • Data Source
    • JaLC
    • CiNii Articles
  • Abstract License Flag
    Disallowed

Report a problem

Back to top